Mice deficient for CCR6 fail to control chronic experimental autoimmune encephalomyelitis
- 1 August 2009
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 213 (1-2) , 91-99
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3 + CD4 + regulatory T cellsProceedings of the National Academy of Sciences, 2008
- Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammationNature Medicine, 2007
- Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathwayJournal of Experimental Medicine, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosisJournal of Neuroimmunology, 2004
- Molecular cloning, functional characterization and mRNA expression analysis of the murine chemokine receptor CCR6 and its specific ligand MIP‐3α1FEBS Letters, 1998
- CCR6, a CC Chemokine Receptor that Interacts with Macrophage Inflammatory Protein 3α and Is Highly Expressed in Human Dendritic CellsJournal of Experimental Medicine, 1997
- T‐lymphocyte entry into the central nervous systemJournal of Neuroscience Research, 1991
- Migration of Hematogenous Cells Through the Blood‐Brain Barrier and the Initiation of CNS InflammationBrain Pathology, 1991